aro-apoc3
Showing 1 - 5 of 5
Familial Chylomicronemia Trial in Worldwide (ARO-APOC3, Placebo)
Recruiting
- Familial Chylomicronemia
- ARO-APOC3
- Placebo
-
Suwanee, Georgia
- +18 more
Aug 3, 2022
Mixed Dyslipidemia Trial in Worldwide (ARO-APOC3, Placebo)
Recruiting
- Mixed Dyslipidemia
- ARO-APOC3
- Placebo
-
Beverly Hills, California
- +31 more
Aug 2, 2022
Dyslipidemias Trial in Australia, New Zealand (ARO-APOC3)
Enrolling by invitation
- Dyslipidemias
- ARO-APOC3
-
Beverly Hills, California
- +36 more
Jan 13, 2023
Severe Hypertriglyceridemia Trial in Worldwide (ARO-APOC3, Placebo)
Active, not recruiting
- Severe Hypertriglyceridemia
- ARO-APOC3
- Placebo
-
Beverly Hills, California
- +72 more
Nov 29, 2022
Hypertriglyceridemia, Familial Chylomicronemia Trial in Australia, Canada, New Zealand (ARO-APOC3, sterile normal saline (0.9%
Completed
- Hypertriglyceridemia
- Familial Chylomicronemia
- ARO-APOC3
- sterile normal saline (0.9% NaCl)
-
Camperdown, New South Wales, Australia
- +9 more
Mar 2, 2021